These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28940471)

  • 1. Screening of exon methylation biomarkers for colorectal cancer via LC-MS/MS strategy.
    Huang Q; Yang Q; Mo M; Ye X; Zhang J; Zhang L; Chen B; Li J; Cai C
    J Mass Spectrom; 2017 Dec; 52(12):860-866. PubMed ID: 28940471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
    BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential methylation of DNA promoter sequences in peripheral blood mononuclear cells as promising diagnostic biomarkers for colorectal cancer.
    Mosallaei M; Siri G; Alani B; Khomartash MS; Naghoosi H; Pourghazi F; Heidari R; Sabet MN; Behroozi J
    J Cancer Res Ther; 2024 Apr; 20(3):993-998. PubMed ID: 39023608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Pasha HF; Radwan MI; Yehia AM; Toam MM
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms.
    Xiao Z; Li B; Wang G; Zhu W; Wang Z; Lin J; Xu A; Wang X
    Clin Chim Acta; 2014 Apr; 431():154-63. PubMed ID: 24518356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylation of RUNX3 by vincristine in colorectal adenocarcinoma cells.
    Moon JW; Lee SK; Lee JO; Kim JH; Kim N; Kim J; Kim HS; Park SH
    Anticancer Res; 2014 Jan; 34(1):133-40. PubMed ID: 24403453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients.
    Zheng Y; Zhang Y; Huang X; Chen L
    Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
    Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
    J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
    Mousavi Ardehaie R; Hashemzadeh S; Behrouz Sharif S; Ghojazadeh M; Teimoori-Toolabi L; Sakhinia E
    Bioengineered; 2017 Sep; 8(5):555-564. PubMed ID: 28140749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MGMT promoter methylation and field defect in sporadic colorectal cancer.
    Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
    J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.